US 12,357,824 B2
Systems, methods and devices for peripheral neuromodulation
Serena HanYing Wong, Palo Alto, CA (US); Kathryn H. Rosenbluth, San Francisco, CA (US); Samuel Richard Hamner, San Francisco, CA (US); Peter Lin, San Jose, CA (US); and Benjamin Pless, Burlingame, CA (US)
Assigned to Cala Health, Inc., San Mateo, CA (US)
Filed by Cala Health, Inc., San Mateo, CA (US)
Filed on Jan. 24, 2024, as Appl. No. 18/421,639.
Application 18/421,639 is a continuation of application No. 17/663,004, filed on May 11, 2022, granted, now 11,918,806.
Application 17/663,004 is a continuation of application No. 16/071,056, granted, now 11,344,722, issued on May 31, 2022, previously published as PCT/US2017/014431, filed on Jan. 20, 2017.
Claims priority of provisional application 62/365,326, filed on Jul. 21, 2016.
Claims priority of provisional application 62/352,462, filed on Jun. 20, 2016.
Claims priority of provisional application 62/281,606, filed on Jan. 21, 2016.
Prior Publication US 2024/0424295 A1, Dec. 26, 2024
Int. Cl. A61N 1/36 (2006.01); A61N 1/04 (2006.01); A61N 1/375 (2006.01)
CPC A61N 1/36007 (2013.01) [A61N 1/0456 (2013.01); A61N 1/0484 (2013.01); A61N 1/36031 (2017.08)] 18 Claims
OG exemplary drawing
 
1. A wearable device for transcutaneous stimulation, the device comprising:
a controller;
at least one sensor configured to be positioned along a skin surface of a patient to measure electrical activity associated with a first afferent nerve, and to provide a measured electrical activity to the controller as feedback information;
wearable band or sleeve configured to be positioned around an ankle and/or foot of the patient, the wearable band or sleeve comprising a first peripheral nerve effector comprising at least one stimulation electrode configured to be positioned to transcutaneously modulate a first afferent nerve pathway when the wearable band is worn; and
wherein the controller comprises a processor configured to:
adjust one or more parameters of a first electrical stimulus based at least in part on information received from the at least one sensor; and
deliver the first electrical stimulus to the first afferent nerve pathway through the first peripheral nerve effector, wherein the device is not configured for implantation within the patient; and
wherein the at least one stimulation electrode is configured to be removable.